Conagen: Next-generation infant formula
Boston-based Conagen has come up with cost effective ways to produce key elements of human breastmilk, from iron-binding protein lactoferrin to a non-GMO version of the human milk oligosaccharide 2’FL - via microbial fermentation, paving the way for a new generation of infant formulas that more closely match the nutrition of breastmilk.
Picture: Gettyimages/stefanovicigor